Wolfgang Wick is Chairman of the Neurology Clinic and Professor of Neurology at Heidelberg University in Germany and is appointed as Division Head for Neuro Oncology at the German Cancer Research Center, Heidelberg, Germany. He was trained in Tübingen and did his medical studies in Bonn, London and Boston. Dr. Wick is active in basic, translational and clinical research with a translational and basic research focus on precision medicine, treatment resistance and immunotherapy.

Dr. Wick serves as a member of the steering committees of NOA, the European Association for Neuro-Oncology (EANO) and the EORTC Brain Tumor Group and is currently Chair of the NOA, and served as President of EANO 2016-2018 as well as Chair of the EORTC Brain Tumor group 2009-2015. He is Spokesperson of the first Neuro Oncology Collaborative Research Centre in Germany (SFB 1389/UNITE) on Understanding and Targeting Resistance in Glioblastoma.